Uses of Streptomyces as nematicides

By applying the fermentation products of Streptomyces commune to seeds and soil, the problem of phasing out chemical nematicides has been solved, and effective control or reduction of plant parasitic nematodes has been achieved, especially with a significant reduction in damage to cyst nematodes, root-knot nematodes, and short-bodied nematodes.

CN123124873APending Publication Date: 2026-11-17SYNGENTA CROP PROTECITON AG
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202580025903.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2024-04-04
Filing Date
2025-04-03
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

The use of existing chemical nematicides is facing the issue of being phased out, and alternative methods need to be developed to control or reduce damage from plant parasitic nematodes.

Method used

Combinations of Streptomyces chrestomyceticus strains are applied to seeds and soil, utilizing their fermentation products such as malnomycin, cyclothiazomycin C, and streptomycin glutarimide metabolites to control or reduce nematode damage to plants.

Benefits of technology

Effectively control or reduce nematode damage to plants, such as damage from cyst nematodes, root-knot nematodes, and short-bodied nematodes, achieving a control or reduction effect of 1% to 100%, specifically such as 5% to 90% reduction in root gall formation or root length improvement.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

This invention relates to a method for controlling or reducing nematode damage to plants, the method comprising applying a composition containing Streptomyces commune to seed material before planting and / or to the soil surrounding the planted seeds or plants.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This invention relates to the use of Streptomyces and / or their fermentation products for the control or reduction of plant-parasitic nematodes. The invention also relates to methods for treating plants to reduce nematode damage by applying seed and / or soil treatments. Background Technology

[0002] Nematodes are microscopic, unsegmented worms known to inhabit almost every type of environment (terrestrial, freshwater, marine). Of the more than 80,000 known species, many are agriculturally significant and are commonly referred to as plant-parasitic nematodes. One such species is the root-knot nematode (a species of the genus *Meloidogyne* spp.), which attacks a wide range of plants, shrubs, and crops. These soil-borne nematodes attack newly formed roots, causing stunted growth, bulging, or gall formation. Chemical nematicides, such as soil fumigants or non-fumigants, have been used for many years to combat infestations. As the use of traditional chemical nematicides such as methyl bromide and organophosphates is phased out, the need has arisen to develop alternative treatment options.

[0003] Such an alternative treatment could be the use of Streptomyces. WO93 / 18135 discloses that Streptomyces dicklowii CR-43 cells or supernatants exhibit nematicidal activity against nematodes such as southern root-knot nematode (Meloidogyne incognita), short-bodied nematode (Pratylenchus penetrans), and Caenorhabiditis elegans.

[0004] Meidani C. et al. (2020) Plants, 9, 699, 1-16. disclosed that supernatants of a few Streptomycete species, particularly *S. monomycini*, *S. colombiensis*, and *S. youssoufensis*, showed activity against root-knot nematode species such as *M. javanica* on Arabidopsis plants.

[0005] KR20230142986 disclosed a mutant strain of Streptomyces species S-N87, which showed increased production of a new spectinabilin with nematicidal activity.

[0006] Improved methods are needed to control or reduce plant-parasitic nematodes by utilizing biological solutions based on the genus Streptomyces. Summary of the Invention

[0007] This invention relates to a method for controlling or reducing nematode damage to plants, the method comprising applying a composition containing a Streptomyces chrestomyceticus strain to pre-planted seeds and / or to the soil surrounding planted seeds or plants, wherein the Streptomyces genus includes Streptomyces chrestomyceticus.

[0008] In another aspect, the present invention relates to the use of compositions comprising Streptomyces commune as nematicides. Detailed Implementation

[0009] The present invention relates to a method for controlling or reducing nematode damage to plants, the method comprising applying a composition comprising Streptomyces and / or its fermentation products to seeds before planting and / or to the soil surrounding the planted seeds or plants, wherein the Streptomyces includes or is *Streptomyces commune*.

[0010] The present invention also relates to the use of a composition containing *Streptomyces commune* as a nematicide. In one embodiment, the use of the composition containing *Streptomyces commune* as a nematicide includes controlling or reducing nematode damage to plants, which includes applying the composition containing *Streptomyces commune* to seeds before planting and / or to the soil surrounding planted seeds or plants.

[0011] Surprisingly, compositions containing *Streptomyces commune* were found to be effective in controlling nematodes such as *Heterodera* sp., *Root-knot* species, and *Pratylenchus* sp., including *Heterodera glycines*, *Southern Root-knot*, and *Pratylenchus zeae*. As used herein, control or reduction of nematode damage to plants should be understood as involving the control or reduction of nematode damage to plants, such as control or reduction of 1% to 100% of nematode damage, for example, 5% to 90%, 10% to 80%, 20% to 70%, or 30% to 60% of nematode damage to plants. For example, damage to plants can be measured by root gall formation or root length. As used herein, "root gall formation" is a deformity or swelling of the root.

[0012] The methods and uses according to the invention do not include methods of treating human or animal bodies by surgery or therapy.

[0013] Applying the composition containing *Streptomyces commune* as disclosed herein to seeds before planting and / or to the soil surrounding planted seeds or plants can be done in any suitable manner, such as by soaking, spraying, fumigation, atomization, broadcasting, brushing, furrow application, drenching, drip irrigation, and / or injection. Applying the composition to seeds includes, for example, soaking the seeds or coating the seeds with one or more coatings.

[0014] Preferably, *Streptomyces commune* contains a nucleotide sequence having at least 99.8%, preferably at least 99.9%, and more preferably at least 99.91%, 99.92%, 99.93%, 99.94%, 99.95%, 99.96%, 99.97%, 99.98%, or 99.99% identity with SEQ ID NO: 1. In one embodiment, *Streptomyces commune* contains a nucleotide sequence having 100% identity with SEQ ID NO: 1. SEQ ID NO: 1 contains the 16SRNA gene of *Streptomyces* species *Saigon* 413, deposited at the Westerdijk Institute with accession number CBS149411.

[0015] In another preferred embodiment, *Streptomyces commune* comprises a genome sequence having at least 91%, 92%, 93%, 94%, 95% identity, preferably at least 96%, 97%, 98%, 99%, with respect to the whole genome of *Streptomyces commune* species Saigon 413, deposited at the Westdick Institute with accession number CBS149411, or the whole genome of *Streptomyces commune* NRRL B-3672. *Streptomyces commune* may also comprise a genome sequence having at least 99.1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, 99.9% identity with the whole genome of *Streptomyces commune* species Saigon 413, deposited at the Westdick Institute with accession number CBS149411, or the whole genome of *Streptomyces commune* NRRL B-3672. Preferably, the composition comprises *Streptomyces commune*, specifically *Saigon* species 413, deposited at the Westdick Institute with accession number CBS149411.

[0016] As used herein, the terms “identity percentage” and “percentage identical” refer to the correlation between two or more nucleotide or amino acid sequences, which can be calculated by: (i) comparing two best-aligned sequences on a comparison window, (ii) determining the number of identical nucleic acid bases (for nucleotide sequences) or amino acid residues (for proteins) in the two sequences to produce a number of matching positions, (iii) dividing the number of matching positions by the total number of positions in the comparison window, and then (iv) multiplying that quotient by 100% to produce the identity percentage. If the “identity percentage” is calculated relative to a reference sequence without specifying a particular comparison window, the identity percentage is determined by dividing the number of matching positions in the alignment region by the total length of the reference sequence. Therefore, for the purposes of this invention, when two sequences (query and subject) are best-aligned (where gaps are allowed in their alignment), the “identity percentage” of the query sequence is equal to the number of identical positions between the two sequences divided by the total number of positions of the query sequence over its length (or on the comparison window), and then multiplied by 100%.

[0017] As disclosed herein, compositions containing *Streptomyces commune* contain the following *Streptomyces* cell counts: 1 10 0 Up to 1 10 14 cfu / g dry weight, for example 1 10 1 Up to 1 10 13 cfu / g dry weight, 1 10 2 Up to 1 10 13 cfu / g dry weight, for example 1 10 3 Up to 1 10 12 cfu / g dry weight, 2 10 3 Up to 2 10 11 cfu / g dry weight, 5 10 3 Up to 5 10 11 cfu / g dry weight, for example 1 10 4 Up to 1 10 10 cfu / g dry weight, 2 10 4 Up to 2 10 10 CFU / g dry weight, e.g., 1 105 Up to 1 10 9 cfu / g dry weight, 2 10 5 Up to 2 10 9 cfu / g dry weight, 5 10 5 Up to 5 10 9 cfu / g dry weight, 1 10 6 Up to 1 10 8 CFU / g dry weight, e.g., 2 10 6 Up to 2 10 8 cfu / g dry weight.

[0018] Streptomyces coromonas can be cultured in a suitable fermentation medium under suitable fermentation conditions, and this culture may optionally include steps known to those skilled in the art for the recovery of Streptomyces coromonas. Typically, fermentation broth is generated during or while culturing Streptomyces coromonas. Suitable fermentation conditions for culturing Streptomyces species are known to those skilled in the art.

[0019] The cultivation of *Streptomyces commune* as disclosed herein involves culturing the microbial strain in the presence of both carbon and nitrogen sources, under aerobic conditions, at a temperature between 15°C and 45°C, preferably between 20°C and 35°C, and most preferably between 25°C and 32°C. Suitable carbon sources may be molasses, such as beet or cane molasses, polysaccharides, flour, starch, sugar, or glucose. Suitable nitrogen sources may be casein hydrolysate, tryptone, ammonium sulfate, ammonia, yeast extract, peptone, or urea. The methods for culturing *Streptomyces* as disclosed herein can be performed in batch, fed-batch, or continuous culture.

[0020] The composition containing *Streptomyces commune* disclosed herein can be the supernatant of the fermentation broth of *Streptomyces commune* disclosed herein. The supernatant of the fermentation broth of *Streptomyces commune* disclosed herein can be produced by methods known in the art, such as by centrifugation or filtration of the fermentation broth.

[0021] In one embodiment, the composition comprising *Streptomyces coronatum* further comprises a metabolite. The metabolite is preferably produced by *Streptomyces coronatum* disclosed herein.

[0022] Preferably, the composition comprises a metabolite, wherein the metabolite comprises or is malonomicin.

[0023] Preferably, the composition comprising *Streptomyces coronatum* further comprises metabolites, such as at least one, at least two, at least four, or at least five metabolites selected from the group consisting of: cyclothiazomycin C; streptimidone; and an oligosaccharide compound according to compound I, wherein compound I comprises metabolites according to C. 53 H 90 N2O 44 The molecular formula is further characterized by the NMR spectra listed in Tables 2 and 3, and is further characterized by structural formula I.

[0024] Formula (I);

[0025] According to formula II, a lipopeptide or its salt, wherein R1 = CH3 or C2H5

[0026] Equation (II);

[0027] And polyene compounds, characterized by C 67 H 115 NO 25 The molecular formula of the polyene is further characterized by an absorption spectrum exhibiting maximum absorption at wavelengths of 235.5 nm, 301.1 nm, 315.8 nm, 330.9 nm, and 348.3 nm when measured in an aqueous acetonitrile solution. The polyene is further characterized by... Figure 10 The light absorption spectrum is shown.

[0028] Preferably, the fermentation product further comprises a metabolite selected from the group consisting of: cyclothiazolycin C; streptomycin glutarimide; an oligosaccharide compound according to compound I, wherein compound I comprises according to C 53 H 90 N2O 44 The molecular formula is further characterized by the NMR spectra listed in Tables 2 and 3, and is further characterized by structural formula I.

[0029] Formula (I);

[0030] According to formula II, a lipopeptide or its salt, wherein R1 = CH3 or C2H5

[0031] Equation (II).

[0032] Compositions containing *Streptomyces commune* as disclosed herein comprise a fermentation broth containing *Streptomyces commune*, preferably a spray-dried or freeze-dried fermentation broth. Spray drying or freeze-drying of the fermentation broth is known in the art.

[0033] The compositions containing Streptomyces commune disclosed herein also include formulations containing Streptomyces commune and / or its fermentation products.

[0034] The compositions disclosed herein are agriculturally acceptable compositions. Preferably, the compositions according to the invention comprise adjuvants, preferably agriculturally acceptable adjuvants. Suitable adjuvants are known in the art and include, for example, solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetting agents, auxiliaries, solubilizers, penetration enhancers, protective colloids, adhesives, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, antifreeze agents, defoamers, colorants, thickeners, and binders.

[0035] The formulations disclosed herein may be in the form of a soluble concentrate (SL), a flowable concentrate (FS) for seed treatment, or a suspension concentrate (SC), and more preferably, a seed treatment slurry applied to seeds. Slurries for seed treatment applications are well known in the art.

[0036] The compositions according to the invention include seed dressing compositions, which relate to liquid compositions that can be used to at least partially or completely cover and / or moisten plant propagation material, and more preferably seeds.

[0037] Seed dressing formulations are applied to seeds in a manner known per se, using the combination and diluents of the present invention, in a suitable seed dressing formulation form (e.g., as an aqueous suspension or as a dry powder with good adhesion to the seeds). Such seed dressing formulations are known in the art.

[0038] Flowable formulations contain solid particles in a liquid (usually water). Flowable concentrates also include suspension concentrates. Flowable formulations typically contain (by wt%): active ingredient (5%-60%), dispersant / wetting agent (1%-10%), rheology modifier (0.1%-0.1%), biocide (0.1%), antifreeze (5%-10%), defoamer (0.2%), adjuvants (up to 25%), and water (to bring the total to 100%).

[0039] The compositions according to the invention are particularly suitable for seed dressing applications on plant propagation materials, especially seeds.

[0040] The compositions disclosed herein comprise 10 wt% to 60 wt% to 50 wt% dry weight, preferably 20 wt% to 50 wt% dry weight, of spray-dried or freeze-dried fermentation broth of Streptomyces commune as disclosed herein.

[0041] Nematodes that can be targeted according to the methods or uses of the present invention include, but are not limited to, species of the genera *Aphelenchoides*, *Bursaphelenchus*, *Criconemella*, *Ditylenchus*, *Dolichodorus*, *Hoplolaimus*, *Globodera*, *Longidorus*, *Paratrichodorus*, *Radopholus*, *Rotylenchulus*, and *Trichodorus*. Species of the genera *Tylenchorhynchus*, *Scutellonema*, *Trichostrongylus*, and *Xiphinema*, such as the nematode species *Aphelenchoides ritzemabosi*, *Belonolaimus longicaudatus*, *Bursaphelenchus xylophilus*, *Caenorhabditis elegans*, *Ditylenchus dipsaci*, *Helicotylenchus multicinctus*, *Haemonchus contortus*, *Southern root-knot nematode*, *Mesocriconema xenoplax*, and *Pratylenchus*. The nematodes include coffeae, Radopholus similis, Rotylenchulus reniformis, Tylenchulus semipenetrans, and Xiphinema americanum.

[0042] Specifically, the nematodes belong to the genera *Helicotylenchus*, *Helicotylenchus* spp., *Helicotylenchus*, *Helicotylenchus* spp., *Rotylenchus* spp., or *Helicotylenchus*. Preferably, the nematodes belong to the nematode species *Meloidogyne hapla*, *Meloidogyne arenaria*, *Meloidogyne javanica*, *Globodera rostochiensis*, *Globodera pallida*, *Heterodera avenae*, *Heterodera schachtii*, or *Heterodera schachtii* and / or *Helicotylenchus*. Preferably, the nematode species include *Helicotylenchus*, *Helicotylenchus*, and / or *Helicotylenchus*.

[0043] As disclosed in this article, the seed is the reproductive part of the plant.

[0044] The terms “plant,” “crop / crops,” “useful plant,” “crop plant,” “agricultural plant,” and “food plant” are used interchangeably in this article.

[0045] According to the present invention, “useful plants” to which the compositions disclosed herein may be applied typically include the following plant species: grapevines; cereals such as wheat, barley, rye, or oats; beets such as sugar beets or forage beets; fruits such as pome, drupes, or soft fruits, such as apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries, or blackberries; legumes such as beans, lentils, peas, or soybeans; oilseed plants such as rapeseed, mustard, poppies, olives, sunflowers, coconuts, castor oilseed plants, cocoa beans, or peanuts; yellow... Cucurbits, such as zucchini, cucumber, or cantaloupe; fiber plants, such as cotton, flax, hemp, or jute; citrus fruits, such as oranges, lemons, grapefruits, or tangerines; vegetables, such as spinach, lettuce, asparagus, cabbage, carrots, onions, tomatoes, potatoes, cucurbitaceous plants, or red peppers; Lauraceae, such as avocados, cinnamon, or camphor; corn; tobacco; nuts; coffee; sugarcane; tea; vines; hops; durian; bananas; natural rubber plants; turf or ornamental plants, such as flowering plants, shrubs, broad-leaved trees, or evergreen trees, such as pines and cypresses.

[0046] Preferably, the plants include soybeans, potatoes, sugar beets, sugarcane, rice, coffee, peas, corn, cotton, fruits and / or vegetables, and preferably, the plants include cucumbers, tomatoes, soybeans and / or corn.

[0047] Useful plants and / or target crops according to the invention include conventional varieties with genetic enhancement or genetic engineering treatments, such as insect-resistant varieties (e.g., Bt. and VIP varieties) along with disease-resistant, herbicide-tolerant varieties (e.g., glyphosate and glufosinate-tolerant maize varieties) and nematode-tolerant varieties. Useful plants include plants transformed using recombinant DNA technology to, for example, synthesize one or more selectively acting toxins, such as those known from toxin-producing bacteria. Examples of toxins that can be expressed include δ-endotoxins, vegetative insecticidal proteins (Vip), insecticidal proteins of nematode-parasitic bacteria, and toxins produced by scorpions, arachnids, wasps, and fungi.

[0048] The plants used in the methods or applications of this invention are plants that need to be protected from nematode damage.

[0049] Methods for controlling or reducing nematode damage to plants include applying a composition containing *Streptomyces commune* at an appropriate dosage. Typical concentration ratios are between 0.1 ppm and 1000 ppm, preferably between 0.1 ppm and 500 ppm of the active ingredient. The application rate per hectare is preferably 1 g to 2000 g of the active ingredient per hectare, more preferably 10 g / ha to 1000 g / ha, and most preferably 10 g / ha to 600 g / ha. When used as a seed leaching agent, a convenient dosage is 10 mg to 1 g of the active substance per kg of seeds. When the composition of the present invention is used to treat seeds, an application rate of 0.001 g to 50 g of the composition per kg of seeds, preferably from 0.01 g / kg to 10 g / kg of seeds, is generally sufficient.

[0050] As used herein, active ingredients include compositions containing Streptomyces commune.

[0051] In one embodiment, the method includes applying an effective amount of the composition containing *Streptomyces commune* as disclosed above, wherein the effective amount comprises 2 10 2 Up to 5 10 17 3 10 2 Up to 5 10 16 5 10 2 Up to 5 10 15 2 10 2 Up to 5 10 14 2 10 2 Up to 5 1013 , preferably 5 10 2 Up to 5 10 12 1 10 3 Up to 5 10 11 5 10 3 Up to 1 10 11 1 10 4 Up to 5 10 10 5 10 4 Up to 1 10 10 1 10 5 Up to 5 10 9 5 10 5 Up to 1 10 9 1 10 6 Up to 5 10 8 5 10 6 Up to 1 10 8 Streptomyces coronum per hectare (CFU).

[0052] The effective dosage of the composition containing *Streptomyces commune* as disclosed above includes 1 g to 10 kg / ha, such as 5 g to 5 kg, such as 10 g to 1 kg / ha, such as 50 g to 800 g / ha, such as 100 g to 700 g / ha, and such as 200 g / ha to 600 g / ha. The weights in g and kg are the dry weight of *Streptomyces commune*.

[0053] In one embodiment, the method according to the invention comprises applying an effective amount of a composition containing *Streptomyces commune* to seeds, wherein the effective amount contains 5 x 10⁻⁶... 2 Up to 5 x 10 15 2x10 3 Up to 5 x 10 14 5 x 10 3 Up to 5 x 10 13 2 x 10 5 Up to 5 x 10 12 , preferably 5 10 2Up to 5 10 12 1 10 3 Up to 5 10 11 5 10 3 Up to 1 10 11 1 10 4 Up to 5 10 10 5 10 4 Up to 1 10 10 1 10 5 Up to 5 10 9 5 10 5 Up to 1 10 9 1 10 6 Up to 5 10 8 5 10 6 Up to 1 10 8 Colony forming units (cfu) of *Streptomyces coronum* per kg of seed as disclosed herein.

[0054] The effective amount of the composition containing *Streptomyces commune* and / or its fermentation products as disclosed above may also include 0.001 g to 100 g / kg of seeds, such as 0.005 g to 80 g / kg of seeds, such as 0.01 g to 50 g / kg of seeds, such as 0.5 g to 10 g / kg of seeds, where the weight is g dry weight of component A containing *Streptomyces commune* / kg dry weight of seeds.

[0055] Suitablely, the composition containing *Streptomyces coronum* can be applied prophylactically, i.e., before the nematode develops, or applied therapeutically, i.e. after the nematode develops. Attached Figure Description

[0056] Figure 1 Compound I in D2O at 600 MHz 1D 1 H NMR spectrum

[0057] Figure 2 Compound I in D2O at 600 MHz 1D 13 C NMR spectrum

[0058] Figure 3The 2D Dept-edited 1H-13C HSQC NMR spectrum of compound I in D2O at 600 MHz shows a positive (CH) signal.

[0059] Figure 4 The 2D Dept 1H-13C HSQC NMR spectrum of compound I in D2O at 600 MHz shows a negative (CH2) signal.

[0060] Figure 5 According to the UV-VIS spectra (200 to 400 nm) of the lipopeptide or lipopeptide antibiotic A (Lipopeptin A) based on Formula II(a) and Formula II(b).

[0061] Figure 6 The precursor of the lipopeptide having formula II(a) is 1204.6 m / z (M+H). + The LC-ESI-MS / MS spectrum depicted fragment peaks consistent with the following amino acids: aspartic acid, hydroxy-glutamine, serine, methyl-asparagine, and methyl-phenylalanine.

[0062] Figure 7 The LC-ESI-MS / MS / MS spectrum of the lipopeptide precursor of Formula II(a) at 294.2 m / z depicts a peak consistent with the molecule C14H25-OH2-C4H5ON.

[0063] Figure 8 The lipopeptide according to formula II(a) in CD3OD at 600 MHz 1D 1 High-field region of H NMR spectrum

[0064] Figure 9 The lipopeptide according to formula II(a) in CD3OD at 600 MHz 1D 1 Low-field region of H NMR spectrum

[0065] Figure 10 The light absorption spectrum (UV-VIS) of polyene compounds from 200 to 500 nm

[0066] Example

[0067] 1. Source, fermentation

[0068] 1.1 Fermentation of Streptomyces species

[0069] Species *Saigon* 413, isolated in Vietnam before 1961, is deposited at the Westdick Institute under accession number CBS149411. The deposit was made by Syngenta Ltd. of the Jealott's Hill Research International Centre, Bracknell (RG42 6EY), Berkshire, UK, in accordance with the provisions of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure.

[0070] The coronavirus streptomyces NRRL B-3672 was obtained from the ARS (NRRL) Culture Collection.

[0071] Streptomyces were cultured in Erlenmeyer flasks in a liquid medium consisting of the following (g / L): casein hydrolysate 10, glucose 40, K2HPO4 1.25, soybean peptone 2, and tryptone 8, and incubated at 28°C in an incubator with shaking at 150 rpm and an amplitude of 25 mm for 4 days.

[0072] Large-scale fermentation

[0073] For large-scale production, fed-batch fermentation is used, and standard procedures are applied to culture Streptomyces species, such as *Streptomyces commune* CBS149411, to high cell density. After harvesting, the culture medium is spray-dried or freeze-dried according to methods known to those skilled in the art.

[0074] The final product after spray or freeze-drying (TGAI) has 1 10 6 Up to 1 10 13 Cell count (cfu / g dry weight). TGAI: Technical grade active ingredient (unformulated product).

[0075] Compare the coronavirus-infected Streptomyces CBS149411 and NRRL B-3672.

[0076] Streptomyces commune strains CBS149411 and NRRL B-3672 were cultured in three different fermentation media known to those skilled in the art: soybean flour-mannitol (SFM), King's medium, and tryptone soybean broth (TSB). 40 ml of medium was dispensed into 125 ml flasks. 130 µl of cell bank suspension was used as inoculum. The inoculated flasks and medium controls were incubated at 28°C with shaking at 180 rpm for 4 days. Incubation was stopped on day 4, and samples were collected and stored at -80°C until testing began. The fermentation broths produced from the different media were tested for their activity against soybean cyst nematodes using the following method. The results are shown in Example 2.

[0077] 1.2 Isolation and whole-genome sequencing of 16S rDNA

[0078] Genomic DNA was isolated from *Streptomyces* species *Saigon* 413 using the method described in Kutchma et al. (1998) *Biotechniques* 24(3):452-457. The 16S rRNA gene was amplified using universal 16S primers and sequenced using Sanger sequencing. The 16S rRNA of *Streptomyces* species *Saigon* 413 is shown in SEQ ID NO:1.

[0079] Whole-genome sequencing of the genomic DNA from the *Streptomyces* species *Saigon*413 was performed using both Pacific Biosciences and Illumina sequencing technologies. The genome was assembled using HFAP4 and refined with Pilon using Illumina reads.

[0080] Table 1 shows the percentage of identity between the whole genome and 16SRNA sequences of Streptomyces species Saigon 413 and Streptomyces NRRL B-3672.

[0081] Table 1.

[0082]

[0083] CBS Westerdijk Fungal Diversity Institute: Uppsalalaan 8, 3584 CT, Utrecht, Netherlands https: / / wi.knaw.nl /

[0084] ARS Culture Collection Center (NRRL), 1815 N. University Street, Peoria, IL 61604, USA - https: / / nrrl.ncaur.usda.gov

[0085] 1.3. Preparations

[0086] Preparation of flowable concentrate formulations of spray-dried or freeze-dried products (microorganisms) using the Croda Crop Care Nouryon formulator toolbox and the formulation techniques disclosed in the following literature: Formulation of Microbial Biopesticides: Beneficial microorganisms, nematodes and seed treatments (412 pages, December 6, 2012). Edited by Burges HD, Springer, ISBN 978-94-011-4926-6.

[0087] The flowable concentrate (FS300) formulation used in the experiment contained 30% spray-dried or freeze-dried TGAI.

[0088] 1.4. Analysis of streptomycin glutarimide, cyclothiazomycin C, and maleoxin

[0089] The structure of cyclothiazomycin C is disclosed on page 3 of WO2015191789 and can be extracted and analyzed according to the methods disclosed in Wang et al. (2010) Appl. Environmental Microbiology, Vol. 76, No. 7, p. 2336. Malenomycin can be extracted and analyzed according to the methods disclosed in Example I(B) of WO2006 / 078939. Streptomycin imide can be extracted and isolated according to the methods disclosed in Lee et al. J. of Antibiotics (2020) 73: pp. 184-188 (including supplementary information).

[0090] 1.5. Oligosaccharide compound I

[0091] Purification of oligosaccharide compound I

[0092] The entire fermentation broth of *Streptomyces commune* CBS149411 (species Saigon 413) was centrifuged to produce an aqueous extract and precipitate. The aqueous extract was lyophilized. The material was resuspended in a minimum volume of water and partitioned with ethyl acetate to remove lipophilic components. The aqueous suspension was retained, lyophilized, and resuspended in a minimum volume of water before being applied to an activated carbon column.

[0093] The column was washed with water and eluted with a water:acetone (50:50) solution.

[0094] Compound I was further purified by hydrophilic interaction liquid chromatography (HILIC) using mass spectrometry-guided fractionation and an ELSD detector. For example, a Waters XBridge Amide, 5 μm, 30 × 100 mm, was used with a gradient of acetonitrile and 10 mM ammonium acetate.

[0095] Characterization of oligosaccharide compound I

[0096] Compound I in the purified fermentation broth was determined according to the method disclosed below.

[0097] Molecular composition and total molecular mass

[0098] The molecular composition and total molecular mass are C 53 H 90 N2O 44 And 1458.487 g, which was determined using MS-MS and NMR spectroscopy as disclosed below.

[0099] solubility

[0100] Oligosaccharide compound I has a solubility of >10,000 ppm in water (pH 7.01) and >9,772 ppm in DMSO.

[0101] MS-MS spectroscopy and liquid chromatography

[0102] Spectra were recorded on an Orbitrap ID-X Tribrid mass spectrometer from Thermo Scientific, equipped with an OptaMax NG heated electrospray source (spray voltage: static, polar ions (V): 3400 (positive ion mode) and 2400 (negative ion mode), sheath gas (Arb): 40, auxiliary gas (Arb): 5, purge gas (Arb): 1, ion transfer tube temperature: 350°C, evaporator temperature: 350°C). Scanning parameters are as follows:

[0103] Experiment 1: MS OT (Orbitrap resolution: 60,000, scan range (m / z): 200 to 2000, RF lens (%): 60, AGC target: standard, maximum injection time mode: auto, microscan: 1, data type: profile, polarity: positive and negative bipolar).

[0104] Experiment 2: tMS2 OT CID (MSn series (n): 2, isolation window (m / z): 1.6, activation type: CID, CID collision energy (%): 30, detector type: Orbitrap, Orbitrap resolution: 30,000, RF lens (%): 60, polarity: negative). The mass spectrometer was connected to a Vanquish Flex UHPLC from Thermo Technologies, using a Vanquish split sampler FT, a Vanquish binary pump F, a Vanquish column oven H, a Vanquish diode array detector FG, and a Vanquish electrosol detector. HPLC conditions included a Thermo Technologies Hypercarb™ porous graphite carbon column, 5 µm (4.6 × 50 mm), PN 35005-054630. Temperature: 40°C, DAD wavelength range: 250 nm to 260 nm, solvent gradient: solvent A: H2O containing 0.1% formic acid, solvent B: CH3CN containing 0.1% formic acid, gradient: 0 min 1% B, 99% A; 4.00 min 50% B, 50% A; 4.25 min 100% B; 4.50 min 100% B; 4.95 min 1% B, 99% A; 6.00 min 1% B, 99% A, flow rate: 1.0 ml / min, injection volume: 2 uL, total run time: 6.0 min.

[0105] NMR spectroscopy

[0106] NMR spectra recorded on a Bruker AVIII 600 NMR spectrometer, which is equipped with a 5 mm Bruker ( 1 H / 19 F) / 13 C / 15 N TCI cryoprobe (equipped with Z-gradient), using standard Bruker pulse sequence. Sample was dissolved in D2O and spectra were recorded at 300°K, with reference to 2.225 ppm (for...). 1 H) and 31.07 ppm (for H) 13 Acetone at point C). Figures 1 to 4 The NMR spectrum of the compound of the present invention is shown.

[0107] single bond1 H- 13 The C-related spectrum contains peaks corresponding to one methyl (CH3) group, 40 methine (CH) groups (listed in Table 2), and 9 methylene (CH2) groups (listed in Table 3).

[0108] In addition, 1D 13 The C spectrum contains signals from three quaternary carbons at 104.7, 159.3, and 175.2 ppm (± 0.1).

[0109] Table 2. Single bonds of oligosaccharide compound I 1 H- 13 Methyl and methine signals in C-correlation spectra and for 1D 1 The proton multiplicity information is analyzed from the H spectrum.

[0110]

[0111]

[0112] Table 3. Single bonds in compound I 1 H- 13 Methylene signals in C-correlation spectra and for 1D 1 The proton multiplicity information is analyzed from the H spectrum.

[0113]

[0114] 1.6. Lipopeptide compounds having Formula II

[0115] Purification of lipopeptides according to Formula II (Formula II(a) and Formula II(b))

[0116] Mycelia from the fermentation broth of *Streptomyces* species *Saigon* 413 were separated by centrifugation, and the supernatant was treated with butanol. The butanol was removed, and the extract was partitioned between water and ethyl acetate. The lipopeptides were purified from the ethyl acetate fraction by preparative reversed-phase (C18) HPLC. The lipopeptides are relatively nonpolar and eluted in the higher organic fraction in a gradient system containing 0.1% formic acid and acetonitrile (0.1% formic acid). The 60% aqueous to 40% aqueous gradient under the above solvent conditions allowed for the separation of the lipopeptide compounds according to Formula II(a) and Formula II(b).

[0117] Through UV-VIS ( Figure 5 Mass spectrometry (MS) Figure 6 and Figure 7 ) and NMR spectroscopy ( Figure 8 and Figure 9 ) Detection of compounds.

[0118] Characterization of lipopeptides with Formula II

[0119] Liquid chromatography and high-resolution mass spectrometry

[0120] Spectra were recorded on an Orbitrap ID-X Tribrid mass spectrometer from Thermo Technologies, equipped with an OptaMax NG heated electrospray source (spray voltage: static, polar ions (V): 3400 (positive ion mode) and 2400 (negative ion mode), sheath gas (Arb): 40, auxiliary gas (Arb): 5, purge gas (Arb): 1, ion transfer tube temperature: 350°C, evaporator temperature: 350°C). Scanning parameters are as follows:

[0121] Experiment 1: MS OT (Orbitrap resolution: 50,000, scan range (m / z): 200 to 2000, RF lens (%): 60, AGC target: standard, maximum injection time mode: auto, microscan: 1, data type: profile, polarity: positive and negative bipolar).

[0122] Experiment 2: tMS2 OT CID (MSn series (n): 2, isolation window (m / z): 1.0, activation type: CID, CID collision energy (%): 30, detector type: Orbitrap, Orbitrap resolution: 30,000, RF lens (%): 60, polarity: positive).

[0123] Experiment 3: tMS2 OT HCD (MSn series (n): 2, isolation window (m / z): 1.0, activation type: HCD, HCD collision energy (%): 30, detector type: Orbitrap, Orbitrap resolution: 30,000, RF lens (%): 60, polarity: positive), Experiment 4: tMS3 OT HCD (MSn series (n): 3, isolation window (m / z): 1.6, activation type: HCD, HCD collision energy (%): 30, MS2 isolation window (m / z): 2, MS2 activation type: HCD, MS2 HCD collision energy (%): 30, detector type: Orbitrap, Orbitrap resolution: 30,000, RF lens (%): 60, polarity: positive). The mass spectrometer was connected to a Vanquish Flex UHPLC from Thermo Technologies, which uses a Vanquish split sampler FT, a Vanquish binary pump F, a Vanquish column oven H, a Vanquish diode array detector FG, and a Vanquish electrosol detector.

[0124] The liquid chromatography conditions included: a Waters ACQUITY UPLC C18 column (1.7 µm, 3.0 × 50 mm, PN186004660); temperature: 40°C; DAD wavelength range: 250 nm to 260 nm; solvent gradient: Solvent A: H₂O containing 0.1% formic acid; Solvent B: CH₃CN containing 0.1% formic acid; gradient: 0 min 10% B, 90% A; 4.00 min 90% B, 10% A; 4.25 min 90% B, 10% A; 4.50 min 10% B, 90% A; 5.00 min 10% B, 90% A; flow rate: 1.0 ml / min; injection volume: 2 μL; total run time: 5.0 min. The purified fermentation broth described above was injected.

[0125] Figure 6 and Figure 7 The LC-ESI-MS / MS / MS spectra of compounds having formula II(a) are shown.

[0126] NMR spectroscopy

[0127] NMR spectra were recorded on a Bruker AVIII 600 NMR spectrometer, which is equipped with a 5 mm Bruker ( 1 H / 19 F) / 13 C / 15 N TCI cryoprobe (equipped with Z-gradient), using standard Bruker pulse sequence. Sample was dissolved in CD3OD and spectra were recorded at 300°K, with reference to 3.31 ppm (for...). 1 The residual solvent signal at H). Figure 8 and Figure 9 Each of them covers half of the 1H NMR spectrum of the compound according to formula II(a).

[0128] Molecular composition and mass

[0129] The molecular composition and mass of the lipopeptides according to Formula II(a) and Formula II(b) were determined using the results of liquid chromatography and high-resolution mass spectrometry as disclosed above. The lipopeptide compounds having Formula II(a) and II(b) have the following composition.

[0130] Formula II (a) Lipopeptide 1204: The molecular composition is C55H85N11O19 and the exact mass is 1203.602.

[0131] Formula II (b) Lipopeptide 1218: The molecular composition is C56H87N11O19, and the exact mass is 1217.618.

[0132] solubility

[0133] Determine the solubility of compounds having formula II(a), compounds having formula II(b), and lipopeptide antibiotic A in water and DMSO:

[0134]

[0135] 1.7. Polyenes

[0136] Purification of polyene compounds

[0137] The spray-dried sample from the culture of *Saigon* species 413 was washed with water. The solid residue was extracted twice with isopropanol, and the isopropanol was removed. The resulting solid was purified by preparative reversed-phase (C18) HPLC using an acetonitrile:water gradient. Further purification was performed by preparative reversed-phase HPLC (using a Zorbax C8 column and eluting with an acetonitrile:water gradient).

[0138] Detection of polyene compounds by UV-VIS Figure 1 ).

[0139] Other polyene compounds

[0140] The Filipin complex, isolated from *Streptomyces filipinensis* (CAS: 11078-21-0), was purchased from a commercial supplier. It is a macrolide antibiotic and is used as a dye in microscopic examination. The sample was a mixture of eight isomers, with Filipin III being the major component. Filipin III had a mass of 654.83 and a molecular composition of C35H58O11.

[0141] Amphotericin B is a macrolide antibiotic isolated from *Streptomyces nodosum* (CAS 1397-89-3) and purchased from a commercial supplier. Its mass is 924.08 and its molecular composition is C47H73NO17.

[0142] Liquid chromatography and high-resolution mass spectrometry

[0143] Spectra were recorded on an Orbitrap ID-X triplet mass spectrometer from Thermo Technologies, equipped with an OptaMax NG heated electrospray source (spray voltage: static, polar ions (V): 3400 (positive ion mode) and 2400 (negative ion mode), sheath gas (Arb): 40, auxiliary gas (Arb): 5, purge gas (Arb): 1, ion transfer tube temperature: 350°C, evaporator temperature: 350°C). Scanning parameters are as follows:

[0144] Experiment 1: MS OT (Orbitrap resolution: 50,000, scan range (m / z): 200 to 2000, RF lens (%): 60, AGC target: standard, maximum injection time mode: auto, microscan: 1, data type: profile, polarity: positive and negative bipolar).

[0145] Experiment 2: tMS2 OT CID (MSn series (n): 2, isolation window (m / z): 1.0, activation type: CID, CID collision energy (%): 30, detector type: Orbitrap, Orbitrap resolution: 30,000, RF lens (%): 60, polarity: positive).

[0146] Experiment 3: tMS2 OT HCD (MSn series (n): 2, isolation window (m / z): 1.0, activation type: HCD, HCD collision energy (%): 30, detector type: Orbitrap, Orbitrap resolution: 30,000, RF lens (%): 60, polarity: positive), Experiment 4: tMS3 OT HCD (MSn series (n): 3, isolation window (m / z): 1.6, activation type: HCD, HCD collision energy (%): 30, MS2 isolation window (m / z): 2, MS2 activation type: HCD, MS2 HCD collision energy (%): 30, detector type: Orbitrap, Orbitrap resolution: 30,000, RF lens (%): 60, polarity: positive).

[0147] The mass spectrometer was connected to a Vanquish Flex UHPLC from Thermo Technologies, which uses a Vanquish split sampler FT, a Vanquish binary pump F, a Vanquish column oven H, a Vanquish diode array detector FG, and a Vanquish electrosol detector.

[0148] The liquid chromatography conditions included: Waters ACQUITY UPLC C18 column (1.7 µm, 3.0 × 50 mm, PN186004660); temperature: 40°C; DAD wavelength range: 250 nm to 260 nm; solvent gradient: solvent A: H₂O containing 0.1% formic acid; solvent B: CH₃CN containing 0.1% formic acid; gradient: 0 min 10% B, 90% A; 4.00 min 90% B, 10% A; 4.25 min 90% B, 10% A; 4.50 min 10% B, 90% A; 5.00 min 10% B, 90% A; flow rate: 1.0 ml / min; injection volume: 2 uL; total run time: 5.0 min.

[0149] Inject the purified fermentation broth as described in Section 1.3.

[0150] The key peak observed is:

[0151] Negative ions: C67H114NO25 [MH] - Expected value: 1332.7685, observed value: 1332.7679

[0152] Positive ion: C67H114NO24 [M-H2O+H] + Expected value: 1316.7725, observed value: 1316.7709

[0153] Positive ion: C67H115NO24 [M-H2O+2H] 2+ Expected value: 658.8899, observed value: 658.8895

[0154] Positive ion: C67H113NO23 [M-2(H2O)+2H] 2+ Expected value: 649.8846, observed value: 649.8843

[0155] Positive ion: C67H111NO22 [M-3(H2O)+2H] 2+ Expected value: 640.8793, observed value: 640.8790

[0156] In the second experiment, the liquid chromatography conditions were as follows: Kinetex Polar C18 column 100A 4.6x100 mm, PN H17-055453; temperature: 40°C; DAD wavelength range: 250 nm to 260 nm; solvent gradient: solvent A: H2O containing 0.1% formic acid, solvent B: CH3CN containing 0.1% formic acid; gradient: 0 min 10% B, 90% A; 1 min 10% B, 90% A; 6.50 min 95% B, 5% A; 8.00 min 95% B, 5% A; 9.00 min 10% B, 90% A; 10.00 min 10% B, 90% A; flow rate: 1.0 ml / min; injection volume: 5 uL; total run time: 10.0 min.

[0157] Under these conditions, the retention time of the polyene compounds was 5.55 to 5.57 minutes.

[0158] The observation quality of the polyene compounds was the same as that of the previous liquid chromatography run (results not shown).

[0159] Molecular composition and mass

[0160] The molecular composition and mass of the polyene compound were determined using the results of liquid chromatography and high-resolution mass spectrometry as disclosed in Section 2.3. The polyene compound had the following composition.

[0161] The molecular composition is C 67 H 115 NO 25 And the precise mass is 1333.7758.

[0162] solubility

[0163] Determine the solubility of the compound in DMSO:

[0164]

[0165] Polyene compounds with a mass of 1333.7758 g were identified in the fermentation broth of several Streptomyces species by isolation and purification according to the methods described in Section 2. The results in Table 2 show that the Streptomyces species producing polyene compounds with the molecular formula C0.05... 67 H 115 NO 25 Polyene compounds.

[0166] Example 1. Use of the Coronamycin-Streptomyces composition against Southern Root-Knot Nematodes

[0167] Material

[0168] Majestene® is obtained from commercial suppliers.

[0169] Prepare the FS300 formulation of Streptomyces commune CBS149411 as described above.

[0170] Method 1: Cucumber seeds

[0171] Cucumber seeds were sown in 200 ml pots and infected with 3000 Southern Root-knot Nematode eggs. On the same day, a 10 ml drenching of the FS300 formulation of CBS149411 TGAI was performed. After 14 days, the plant roots were washed out, and root gall formation was assessed according to the adapted Zeck index (1.), and the total root length was measured using WhinRhizo Pro 2005 software.

[0172] Table 4.

[0173]

[0174] Method 2: Tomato seeds

[0175] Tomato seeds were sown in 45 ml pots and infected 7 days after sowing with 1,000 second-instar larvae (J2) of the southern root-knot nematode. On the day of infection, a drenching application of the FS300 formulation of CBS149411 was performed at a 1:1 ratio with the adhesive, and the adhesive was also tested individually at different application rates to test the effect of the adhesive alone. Root gall ratings (adapted Zeck index (1)) were assessed 23 days after infection. Tests were conducted under greenhouse conditions.

[0176] Table 5

[0177]

[0178] The polymer / adhesive alone was also tested at different application rates (1.5 mg / pot to 41 mg / pot), in which no effect on nematodes / plants was observed.

[0179] Method 3

[0180] Invasion assay of maize short-bodied nematode on maize

[0181] Maize seeds (Falkone variety) were treated with a given amount of the test product. The treated seeds were sown in potting soil in pots. Three days after sowing, the pots were infected with 1000 Graham maize short-bodied nematode larvae. Seven days after infection, the plants were cut, the roots were removed from the soil, and gently washed. The roots were bleached and stained with acid fuchsin according to the method from Bybd DW et al. 1983. Finally, the root samples were examined under a dissecting microscope, and the number of nematodes was counted. The efficacy of the treatment was calculated using the Abbott formula.

[0182] Table 6

[0183]

[0184] Method 4. Determination of invasion of southern root-knot nematode on soybeans

[0185] Soybean seeds (toliman variety) were treated with a given amount of the test product. The treated seeds were sown in potting soil in pots. On the day of sowing, the pots were infected with 20,000 eggs of the southern root-knot nematode (Meloidogyne incognita Chitwood). Fourteen days after infection, the plants were cut, the roots were removed from the soil, and gently washed. The roots were bleached and stained with acid fuchsin according to the method from Bybd DW et al. (1983). Finally, the root samples were examined under a dissecting microscope, and the number of nematodes was counted. The efficacy of the treatment was calculated using the Abbott formula.

[0186] Table 7.

[0187]

[0188] The results in Tables 4 through 7 show that the composition of *Streptomyces commune* CBS 149411 reduced root damage to cucumber, tomato, and soybean seeds / roots caused by the southern root-knot nematode. Furthermore, *Streptomyces commune* CBS 149411 reduced root damage to maize seeds / roots caused by the maize short-bodied nematode.

[0189] Example 2. Activity of *Streptomyces coronaria* strains against soybean cyst nematodes.

[0190] Soybean seeds (toliman variety) were treated with a given amount of the test product. The treated seeds were sown in potting soil in pots. On the day of sowing, the pots were infected with 2000 soybean cyst nematode (Ichinohe) eggs. Fourteen days after infection, the plants were cut, the roots were removed from the soil, and gently washed. The roots were bleached and stained with acid fuchsin according to the method from Bybd DW et al. 1983. Finally, the root samples were examined under a dissecting microscope, and the number of nematodes was counted. The efficacy of the treatment was calculated using the Abbott formula.

[0191] The results in Tables 7 and 8 show that, as disclosed in Section 1.1, both *Streptomyces coronaria* CBS149411 and NRRL B-3672 cultured on soybean flour mannitol (SFM), King's and tryptone soybean culture (TSB) media are active against nematodes such as soybean cyst nematode on soybean roots.

[0192] Table 8. Activity of Streptomyces coronacioides CBS149411 and NRRL B-3672 against soybean cyst nematode on soybean roots

[0193]

[0194] Table 9. Activity of Streptomyces coronacioides CBS149411 and NRRL B-3672 against soybean cyst nematode on soybean roots

[0195]

[0196] References:

[0197] (1)Abbott WS.A method of computing the effectiveness of aninsecticide.J Econ Entomol (1925) 18:265–267

[0198] (2)Bybd DW, Kirkpatrick T, Barker KR.An improved technique for clearing and staining plant tissues for detection of nematodes.J Nematol.1983Jan;15(1):142-3. PMID:19295781;PMCID:PMC2618249.

[0199] (3)Zeck, W.M., 1971. A rating scheme for field evaluation of root-knot infestations. Pflanzenschutz-Nachr. Bayer AG 24, 141–144. PCT / RO / 134 Table

Claims

1. A method for controlling or reducing nematode damage to plants, the method comprising applying a composition containing Streptomyces commune to seeds before planting and / or to the soil surrounding the planted seeds or plants.

2. Use of compositions containing Streptomyces commune as nematicides.

3. The use according to claim 2, wherein the use includes controlling or reducing nematode damage to plants, the control or reduction comprising applying the composition comprising the Streptomyces commune to seeds before planting and / or to the soil surrounding the planted seeds or plants.

4. The method according to claim 1 or the use according to claim 2 or 3, wherein the *Streptomyces commune* comprises a nucleotide sequence having at least 99.8% identity with SEQ ID NO: 1, and / or wherein the *Streptomyces commune* has at least 91% genome identity with the whole genome of *Streptomyces* species *Saigon* 413 deposited at the Westdick Institute with accession number CBS149411.

5. The method according to any one of claims 1 to 4 or the use according to any one of claims 2 to 4, wherein the *Streptomyces commune* is *Saigon* species 413, deposited at the Westdick Institute with accession number CBS149411.

6. The method according to claim 1 or 5, or the use according to any one of claims 2 to 5, wherein the composition comprises a cell count of 10-1. 0 Up to 10 14 Streptomyces coronum cfu / g dry weight.

7. The method according to any one of claims 1, 3 to 6, or the use according to any one of claims 2 to 6, wherein the composition further comprises a metabolite.

8. The method or use according to claim 7, wherein the metabolite comprises maleoxin.

9. The method according to any one of claims 1, 3 to 8, or the use according to any one of claims 2 to 8, wherein the composition further comprises at least one metabolite selected from the group consisting of: cyclothiazolycin C; streptomycin glutarimide; an oligosaccharide compound according to compound I, wherein compound I comprises according to C 53 H 90 N2O 44 The molecular formula is further characterized by the NMR spectra listed in Tables 2 and 3, and is further characterized by structural formula I. Equation (I); According to formula II, a lipopeptide or its salt, wherein R1 = CH3 or C2H5 Equation (II); And polyene compounds, characterized in that According to C 67 H 115 NO 25 The molecular formula of the polyene is further characterized by an optical absorption spectrum having maximum absorption at wavelengths of 235.5 nm, 301.1 nm, 315.8 nm, 330.9 nm and 348.3 nm when measured in an aqueous acetonitrile solution.

10. The method according to any one of claims 1 to 3 to 9 or the use according to any one of claims 2 to 9, wherein the composition comprises a fermentation broth, preferably a spray-dried fermentation broth or a freeze-dried fermentation broth, or a preparation.

11. The method of claim 10 or the use of claim 9, wherein the formulation comprises a flowable concentrate.

12. The method according to any one of claims 1, 3 to 11 or the use according to any one of claims 2 to 11, wherein the nematode belongs to the genus *Root-knot Nematode*, *Cyclone*, *Spiral Nematode*, *Heterodermella*, *Cyclone*, or *Brief-bodied Nematode*, preferably the nematode belongs to the nematode species *Southern Root-knot Nematode*, *Northern Root-knot Nematode*, *Peanut Root-knot Nematode*, *Java Root-knot Nematode*, *Potato Golden Nematode*, *Potato White Nematode*, *Soybean Cyclone*, *Gracilaria Cyclone*, *Beet Cyclone*, or *Corn Short-bodied Nematode*.

13. The method according to any one of claims 1, 3 to 12 or the use according to any one of claims 2 to 12, wherein the plant includes soybean, potato, sugar beet, sugarcane, rice, coffee, pea, corn, cotton, fruit and / or vegetable, preferably wherein the plant includes cucumber, tomato, soybean and / or corn.

14. The method according to any one of claims 1, 3 to 13 or the use according to any one of claims 2 to 13, wherein the composition containing *Streptomyces commune* is applied at an application rate of 1 g to 2000 g of the composition containing *Streptomyces commune* per hectare, or at an application rate of 0.001 to 50 g of the composition containing *Streptomyces commune* per kg of seed.

15. The method or use according to any one of the preceding claims, wherein the composition is applied preventively or therapeutically.

Citation Information

Patent Citations

  • Nematocidal and fungicidal streptomyces dicklowii biopesticide

    WO1993018135A1

  • Use of malonomicin and analogs in fungicidal applications

    WO2006078939A1

  • Reactivity-based screening for natural product discovery

    WO2015191789A2